| Tue, Jun 30, 2009 | | • | BVF Sells $2.4M Worth of Ligand Pharma
TheStreet.com (Tue, Jun 30)
| | Thu, Jun 25, 2009 | | • | Ligand Licenses Patents for Desulfated Heparin Technology to ParinGenix
Business Wire (Thu, Jun 25)
| | Wed, Jun 24, 2009 | | • | LIGAND PHARMACEUTICALS INC Files SEC form 8-K, Entry into a Material Definitive Agreement
EDGAR Online (Wed, Jun 24)
| | Wed, Jun 17, 2009 | | • | Ligand Initiates Clinical Trial with the Selective Androgen Receptor Modulator LGD-4033, a Potential Treatment of Muscle and Bone Disorders
Business Wire (Wed, Jun 17)
| | Tue, Jun 16, 2009 | | • | 4-Star Stocks on the Upswing
at Motley Fool (Tue, Jun 16)
| | Mon, Jun 1, 2009 | | • | LIGAND PHARMACEUTICALS INC Files SEC form 8-K, Change in Directors or Principal Officers, Financial Statements and Ex
EDGAR Online (Mon, Jun 1)
| | Thu, May 21, 2009 | | • | LIGAND PHARMACEUTICALS INC Financials
EDGAR Online Financials (Thu, May 21)
| | Mon, May 11, 2009 | | • | LIGAND PHARMACEUTICALS INC Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements an
EDGAR Online (Mon, May 11)
| | • | LIGAND PHARMACEUTICALS INC Files SEC form 10-Q, Quarterly Report
EDGAR Online (Mon, May 11)
| | • | CORRECTING and REPLACING Ligand Pharmaceuticals Announces First Quarter Results
Business Wire (Mon, May 11)
| | Wed, May 6, 2009 | | • | LIGAND PHARMACEUTICALS INC Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements an
EDGAR Online (Wed, May 6)
| | • | Ligand Pharmaceuticals Announces First Quarter Results
Business Wire (Wed, May 6)
| | • | Q1 2009 Ligand Pharmaceuticals Incorporated Earnings Release - After Market Close
CCBN (Wed, May 6)
| | Thu, Apr 30, 2009 | | • | 5 Cold Stocks Heating Up
at Motley Fool (Thu, Apr 30)
| | • | 5 Cold Stocks Heating Up
at Motley Fool (Thu, Apr 30)
| | Tue, Apr 28, 2009 | | • | Ligand to Hold First Quarter Results Conference Call on May 6
Business Wire (Tue, Apr 28)
| | Mon, Apr 27, 2009 | | • | Wyeth and Ligand bone drug gets Europe approval
AP (Mon, Apr 27)
| | • | Ligand Announces Approval in Europe of CONBRIZA for Treatment of Postmenopausal Osteoporosis in Women at Increased Risk of Fracture
Business Wire (Mon, Apr 27)
| | Wed, Apr 22, 2009 | | • | LIGAND PHARMACEUTICALS INC Files SEC form 8-K, Change in Directors or Principal Officers
EDGAR Online (Wed, Apr 22)
| | Thu, Apr 16, 2009 | | • | 3 Stocks Ready to Roar
at Motley Fool (Thu, Apr 16)
|
Add LGND News to My Yahoo!:
 
| |
|
0.06% Nasdaq 0.00%
Headlines
